English

• 22 Oct, 2026
  NOTICE OF EXTRAORDINARY GENERAL MEETING IN SPAGO NANOMEDICAL AB (PUBL)
• 22 Oct, 2026
  The Board of Directors of Spago Nanomedical has resolved, subject to the approval of the general meeting, to apply for delisting from the Nasdaq First North Growth Market
• 22 Oct, 2026
  Bulletin from the Extraordinary General Meeting of Spago Nanomedical AB
• 29 Sep, 2026
  Spago Nanomedical to participate in several international industry conferences during autumn 2026
• 21 Sep, 2026
  NOTICE OF EXTRAORDINARY GENERAL MEETING IN SPAGO NANOMEDICAL AB (PUBL)
• 20 Aug, 2026
  Spago Nanomedical interim report January-June 2026
• 18 Jun, 2026
  Spago Nanomedical announces outcome of rights issue
• 10 Jun, 2026
  Bulletin from the 2026 Annual General Meeting of Spago Nanomedical AB
• 3 Jun, 2026
  The subscription period in Spago Nanomedical’s rights issue begins today
• 2 Jun, 2026
  Spago Nanomedical publishes information document in connection with forthcoming rights issue